Sentences with phrase «report on this trial»

been reported by the High Court in its report on the trial of an election petition to have been proved guilty of a corrupt practice, --

George had been reporting on the trial of Peter Liang, an NYPD officer who fatally shot an unarmed man in a public housing stairwell in 2014.

In a report on the trials, published online Feb. 8 in Neurology, the investigators conclude that the diet is a «feasible» option for people with so - called super-refractory status epilepticus (SRSE), the most severe seizure classification, in which up to an estimated 60 percent of patients die once they develop this type of seizure.

We published a full report on this trial, which includes examples of portfolios from across the attainment range.

However, as Turkewitz observes, the temptation to report on trials via Twitter is something that will now likely present an issue for numerous courts.

CORRECTION: An earlier version of this post incorrectly stated that Kansas - based reporter Ron Sylvester would be reporting on a trial in Colorado.

Not exact matches

Following a devastating clinical trial setback earlier this month for its lead experimental product, a cannabidiol gel, in epilepsy, the firm reported another trial failure on Monday for the product in treating knee pain due to osteoarthritis.

The Insurance Commission of Western Australia increased spending on the Bell Group litigation to $ 9.6 million last financial year, while also revealing in its annual report it has applied to the Supreme Court for a single trial to cover all related matters.

Co-working real estate startup WeWork is readying a new startup incubator, called Area 51 Paradise Ranch, which will be trialed at the company's Tribeca office space, Wired reported on Monday.

Berlusconi, who has been sentenced for tax fraud and is on trial accused of having sex with an under - aged prostitute, is reported to have made rude remarks about Merkel's appearance in a phone call wiretapped by investigators, though he denies this.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.

• And speaking of new shows... Amanda Knox, the American student who stood trial in Italy for the 2007 murder of her roommate, wants to draw attention to other women who were shamed for their sexuality and womanhood on her new show, The Scarlet Letter Reports, for Vice Media's Broadly.

CNBC's David Faber reports the latest on the Department of Justice's antitrust trial over the AT&T - Time Warner merger.

The judge in charge of the John Edwards trial is telling jurors to «go back to work» on deliberating the case, CNN's Jeffrey Toobin reported.

The biopharma world went into a bit of a frenzy on Tuesday as Nature reported that a team of Chinese scientists had become the first in the world to launch human trials of the groundbreaking CRISPR gene - editing technology.

The court filing says van der Zwaan not only spoke with both Gates and the unnamed person about a report on a controversial Ukrainian politician's trial, but also destroyed evidence Mueller's office was seeking, including the September 2016 email.

Parker was acquitted in the rape case more than a decade ago and Celestin had his sexual assault conviction overturned on appeal (a higher court deemed his trial attorney ineffective), but the two men have come under fire once again as the media reports troubling details from the case, which included accusations that Parker and Celestin, then both 19, had sex with a Penn State freshman while she was unconscious after a night of heavy drinking.

«DOJ trial attorney Amy Matchison said at a court hearing before U.S. Magistrate Judge Jacqueline Scott Corley Thursday that the IRS has been in talks with Coinbase about narrowing its request to only items the agency would need to look for unreported income,» reported The Recorder, a legal site that reported on the hearing.

During the second trial, prosecutors focused less on Kozwolski's opulent lifestyle and the notorious toga party and spent more time talking about accounting issues, The Times reported.

To access BI Intelligence's full reports on Location - Based Mobile Marketing, as well as full - access to our archive of in - depth reports, charts and data, sign up for a free trial subscription.

The study found that, during the last six years, foriegn journalists have been assaulted while reporting on land protests in Zhejiang and an activist's trial in Sichaun, among other incidents.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The show will be based on investigative reporting by BuzzFeed writer Katie J.M. Baker, and will be similar to the popular Netflix series «Making a Murderer,» which followed the trial and incarceration of an alleged killer.

Juno's setbacks contrast with the biologics license application planned this year by Novartis, and the rolling BLA in progress by Kite Pharma — which on Tuesday reported positive 6 - month trial data for its CAR T - cell lead candidate.

NBC 6's Tony Pipitone reports on the latest developments related to the Nikolas Cruz trial, particularly on whether he can afford his own defense.

And the San Francisco Chronicle reports that over 100 clinical trials listed on the ClinicalTrials.gov website feature Fitbit trackers in addition to those trials using the Apple Watch, Jawbone, Garmin, Pebble and other devices.

Zelia Rosenzweig shares how she has focused on improving the pre-sales cycle by removing data silos and one - off reports to give the entire trial team better insight and access into new customer opportunities.

A March 28, 2018, research note by JMP Securities analyst Michael King indicated that at the recent International Symposium on Amyloidosis in Japan, Alnylam Pharmaceuticals Inc. (ALNY: NASDAQ) reported multiple sets of results of clinical trials, separately evaluating its investigational RNA interference (RNAi) therapeutics patisiran and ALN - TTRsc02.

Following disappointing Phase 3 results for the RSV vaccine in older adults, Novavax, Inc. (NASDAQ: NVAX) reported mixed results for a Phase 2 trial of the vaccine on older adults who were reimmunized.

More details on a pivotal clinical trial mixed with a bullish analyst report send shares screamin...

There might be a field report from a brave, exuberant missionary, or an expert's measured critique of the sex and violence on television (ending not with a plea for censorship, but with an expression of dismay — these people learned something from the Scopes trial).

Richard and I traveled down to Maryland for the trial of the famous Catonsville Nine, partly to report on it, partly to give Dan (increasingly skeptical) moral support.

The Prisoner was now to be brought to trial In the account of the proceedings given in the gospels we have, in appearance, reports of two separate trials, one before a Jewish court, the other before the Roman governor, each ending in condemnation on a capital charge — but a different charge in each.

The most senior French Catholic leader is to face trial for failing to report child abuse, a court ruled on Tuesday.

Fr Barbarin, who was once tipped as a successor to Pope Francis, will go on trial in April for not reporting the abuse.

As of this writing, the major network nightly news programs have not even covered the trial, and most reporting outside of the Philadelphia area has been sporadic, placed on inside pages, and written blandly — the kind of low - voltage reportage easily lost in the constant white noise of media overload.

After the trial, however, reports by the semi-official Fars News Agency on September 30 indicated that the charges against Nadarkhani have since changed and the pastor is now charged with rape and extortion.

The historian R. M. Cornelius, who has written a great deal on the Scopes Trial, reports, «A review of the trial press coverage reveals that the typical newsman had both an ear for a good story and a mouth hungry for Bryan's blood.&rTrial, reports, «A review of the trial press coverage reveals that the typical newsman had both an ear for a good story and a mouth hungry for Bryan's blood.&rtrial press coverage reveals that the typical newsman had both an ear for a good story and a mouth hungry for Bryan's blood.»

The Washington Post has not published original reporting on this during the trial and The New York Times saw fit to run one original story on A-17 on the trial's first day.

That's just one of the reasons FloraGLO is trusted most by doctors — based on the results of the National Disease and Therapeutic Index syndicated report among physicians who recommend a dietary supplement with lutein for eye health between September 2009 and September 2010 — and is the brand being used in the National Eye Institute's AREDS 2 trial.

Thus far, no adverse environmental effects have been reported on the nine completed field trials.

A 1961 report on vegetable variety trials at the Northeastern Branch Station, in Tucumcari, mentioned green chile for commercial processing as a promising crop, although hail in late spring may be a production hazard.

In the first human trial, subjects on a diet of A2 milk reported less abdominal pain, compared to a diet of regular A1 milk.

Bramall signed a pro deal with the Gunners after impressing on trial, as reported today by the Arsenal website.

Sir: You reported in the story on the Jan Kemp trial that the Athens Banner - Herald / Daily News had called for the dismissal of University of Georgia president Fred Davison in an editorial published Sunday, Feb. 16.

Manchester United have taken former Manchester City academy player Sam Grimshaw on trial, reports ESPN.

As reported by The Sun, his father Arthur Chorazka said: «Kacper went to Rangers on trial and I know their goalkeeping coach Jim Stewart liked him.

The court fight could put modern television journalism on trial and highlight the power of language in the Internet Age: In the wake of the reports on «World News with Diane Sawyer,» the term «pink slime» went viral.

This month our participants have reported on weeklong trials to make their lives a little greener and gentler.